About HiFiBiO
HiFiBiO is a company based in Paris (France) founded in 2013 by Liang Schweizer.. HiFiBiO has raised $179.5 million across 3 funding rounds from investors including Kite Pharma, Legend Holdings and Mirae Asset Financial Services. HiFiBiO has completed 1 acquisition, including H-Immune. HiFiBiO offers products and services including DIS® Platform, EMUNKITUG, and HFB200604. HiFiBiO operates in a competitive market with competitors including GSK, Metabolon, Avidity Biosciences, Sutro Biopharma and Maze Therapeutics, among others.
- Headquarter Paris, France
- Founders Liang Schweizer
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hifibio Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$179.5 M (USD)
in 3 rounds
-
Latest Funding Round
$75 M (USD), Series D
Jun 14, 2021
-
Investors
Kite Pharma
& 19 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HiFiBiO
HiFiBiO offers a comprehensive portfolio of products and services, including DIS® Platform, EMUNKITUG, and HFB200604. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables drug discovery through single cell tech and AI analytics
Antibody for potential oncology treatment in clinical trials
Antibody targeting inflammatory and immunology diseases
Unlock access to complete
Unlock access to complete
Funding Insights of HiFiBiO
HiFiBiO has successfully raised a total of $179.5M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $75.0M
-
First Round
First Round
(16 May 2018)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series D - HiFiBiO | Valuation | Mirae Asset Financial Services | |
| Aug, 2019 | Amount | Series C - HiFiBiO | Valuation | IDG Capital | |
| May, 2018 | Amount | Series B - HiFiBiO | Valuation | Sequoia Capital China , LYFE Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HiFiBiO
HiFiBiO has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include Kite Pharma, Legend Holdings and Mirae Asset Financial Services. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Tech & Offline focused early & growth stage VC firm investing in China
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HiFiBiO
HiFiBiO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include H-Immune. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing MAb immunotherapies to treat cancer
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - HiFiBiO
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hifibio Comparisons
Competitors of HiFiBiO
HiFiBiO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Metabolon, Avidity Biosciences, Sutro Biopharma and Maze Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hifibio
Frequently Asked Questions about HiFiBiO
When was HiFiBiO founded?
HiFiBiO was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is HiFiBiO located?
HiFiBiO is headquartered in Paris, France.
Who is the current CEO of HiFiBiO?
Liang Schweizer is the current CEO of HiFiBiO. They have also founded this company.
Is HiFiBiO a funded company?
HiFiBiO is a funded company, having raised a total of $179.5M across 3 funding rounds to date. The company's 1st funding round was a Series B of $37.5M, raised on May 16, 2018.
What does HiFiBiO do?
HiFiBiO was established in 2013 in Paris, France, within the biotechnology sector. A platform is provided for antibody-based drug discovery, where entire B cell populations are screened through high-throughput, single-cell, functional methods. Next-generation sequencing and rapid DNA synthesis are integrated to target rare antibodies. Operations emphasize efficient identification and development of therapeutic candidates for pharmaceutical applications.
Who are the top competitors of HiFiBiO?
HiFiBiO's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does HiFiBiO offer?
HiFiBiO offers DIS® Platform, EMUNKITUG, and HFB200604.
How many acquisitions has HiFiBiO made?
HiFiBiO has made 1 acquisition, including H-Immune.
Who are HiFiBiO's investors?
HiFiBiO has 20 investors. Key investors include Kite Pharma, Legend Holdings, Mirae Asset Financial Services, Sequoia Capital, and Sherpa Healthcare Partners.